GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir

Pill with imprint GSI is Pink, Capsule-shape and has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg. It is supplied by Gilead Sciences, Inc.

Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI

Complera

Generic Name: emtricitabine/rilpivirine/tenofovir
Imprint: GSI
Strength: emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
Color: Pink
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antiviral combinations
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Gilead Sciences, Inc.
National Drug Code (NDC): 61958-1101
Inactive Ingredients: microcrystalline cellulose, lactose monohydrate, polysorbate 20, croscarmellose sodium, magnesium stearate, corn starch, FD&C Blue No. 2, aluminum oxide, ferric oxide red, FD&C Yellow No. 6, titanium dioxide, triacetin
Note: Inactive ingredients may vary.